Earnings Summary

Nanobiotix Sa - Adr’s revenue jumped 147.78% since last year same period to $1.65Mn in the Q2 2023. On a quarterly growth basis, Nanobiotix Sa - Adr has generated -4.47% fall in its revenue since last 3-months.

Nanobiotix Sa - Adr’s net profit jumped 46.7% since last year same period to $-14.05Mn in the Q2 2023. On a quarterly growth basis, Nanobiotix Sa - Adr has generated 54.21% jump in its net profits since last 3-months.

Nanobiotix Sa - Adr’s net profit margin jumped 78.49% since last year same period to -853.29% in the Q2 2023. On a quarterly growth basis, Nanobiotix Sa - Adr has generated 52.07% jump in its net profit margins since last 3-months.

Nanobiotix Sa - Adr’s earning per share (EPS) estimates for the current year stand at -1.05.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Nanobiotix Sa - Adr’s return on assets (ROA) stands at -0.48.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Nanobiotix Sa - Adr’s return on equity (ROE) stands at -1.99.